Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 13/20 | 0.48 |
| ▸ | AR | P10275 | 6/20 | 0.42 |
| ▸ | PGR | P06401 | 5/20 | 0.42 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9626846 | 1.00 | CYP19A1 (0.48) | CYP19A1ARPGRNR3C2 | |
| SCHEMBL9627566 | 1.00 | CYP19A1 (0.48) | CYP19A1ARPGRNR3C2 | |
| SCHEMBL9626745 | 1.00 | CYP19A1 (0.48) | CYP19A1ARPGRNR3C2 | |
| SCHEMBL6849006 | 0.85 | CYP19A1 (0.36) | CYP19A1AR | |
| SCHEMBL9626851 | 0.84 | CYP19A1 (0.49) | CYP19A1ARPGRNR3C2 | |
| SCHEMBL7030182 | 0.84 | CYP19A1 (0.49) | CYP19A1ARPGRNR3C2 | |
| SCHEMBL9626840 | 0.84 | CYP19A1 (0.46) | CYP19A1ARPGRNR3C2 | |
| SCHEMBL9626738 | 0.84 | CYP19A1 (0.46) | CYP19A1ARPGRNR3C2 | |
| SCHEMBL9627560 | 0.84 | CYP19A1 (0.46) | CYP19A1ARPGRNR3C2 | |
| SCHEMBL7020267 | 0.83 | CYP19A1 (0.55) | CYP19A1ARPGRNR3C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0920441-B1 | 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENT | SCHERING AG (DE) | 2003-01-29 | — | — | EP | disclosed |
| EP-0906332-B1 | 7ALPHA-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7ALPHA-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS | SCHERING AG (DE) | 2001-11-28 | — | — | EP | disclosed |
| US-6288051-B1 | ESTROGEN-DEPENDENT BREAST CANCER TREATMENT | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-09-11 | — | — | US | disclosed |
| US-6271403-B1 | PURE ANTIESTROGENS, OR ESTROGENIC ANTIESTROGENS WITH ESTROGENIC PARTIAL ACTION. | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-08-07 | — | — | US | disclosed |
| US-5986115-A | STEROIDS WITH FLUORO GROUPS AND ETHER OR ESTER GROUPS | SCHERING AG (DE) | 1999-11-16 | — | — | US | disclosed |
| EP-0920441-A1 | 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7ALPHA-(EPSILON-AMINOALKYL)-ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENT | SCHERING AKTIENGESELLSCHAFT (DE) | 1999-06-09 | — | — | EP | disclosed |
| US-5866560-A | ESTROGEN INHIBITORS; TUMOR THERAPY; HORMONE REPLACEMENT THERAPY | SCHERING AG (DE) | 1999-02-02 | — | — | US | disclosed |
| WO-1998007740-A1 | 7α-(κ-AMINOALKYL)ESTRATRIENES, PROCESS FOR PREPARING THE SAME, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 7α-(κ-AMINOALKYL)ESTRATRIENES AND THEIR USE FOR PREPARING MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-02-26 | — | — | WO | disclosed |